Goker-Alpan O - Search Results

1

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease.

Ivanova MM, Dao J, Kasaci N, Adewale B, Nazari S, Noll L, Fikry J, Sanati AH, Goker-Alpan O. Ivanova MM, et al. PLoS One. 2021 Oct 25;16(10):e0247211. doi: 10.1371/journal.pone.0247211. eCollection 2021. PLoS One. 2021. PMID: 34695170 Free PMC article.

2

Therapeutic approaches to bone pathology in Gaucher disease: past, present and future.

Goker-Alpan O. Goker-Alpan O. Mol Genet Metab. 2011 Dec;104(4):438-47. doi: 10.1016/j.ymgme.2011.08.004. Epub 2011 Aug 11. Mol Genet Metab. 2011. PMID: 21889384 Free article. Review.

3

Commentary on "Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease" by Zimran et al.

Goker-Alpan O. Goker-Alpan O. Blood Cells Mol Dis. 2013 Feb;50(2):138-9. doi: 10.1016/j.bcmd.2012.09.007. Epub 2012 Oct 18. Blood Cells Mol Dis. 2013. PMID: 23083682 No abstract available.

4

Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease.

Sønder SU, Limgala RP, Ivanova MM, Ioanou C, Plassmeyer M, Marti GE, Alpan O, Goker-Alpan O. Sønder SU, et al. Blood Cells Mol Dis. 2016 Jul;59:8-15. doi: 10.1016/j.bcmd.2016.02.003. Epub 2016 Feb 15. Blood Cells Mol Dis. 2016. PMID: 27282561

5

New Directions in Gaucher Disease.

Horowitz M, Elstein D, Zimran A, Goker-Alpan O. Horowitz M, et al. Hum Mutat. 2016 Nov;37(11):1121-1136. doi: 10.1002/humu.23056. Epub 2016 Aug 21. Hum Mutat. 2016. PMID: 27449603 Review.

6

Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease.

Limgala RP, Jani C, Ioanou C, Alpan O, Goker-Alpan O. Limgala RP, et al. Blood Cells Mol Dis. 2018 Feb;68:81-85. doi: 10.1016/j.bcmd.2016.10.015. Epub 2016 Oct 28. Blood Cells Mol Dis. 2018. PMID: 27839980 Clinical Trial.

7

Gaucheromas: When macrophages promote tumor formation and dissemination.

Ivanova M, Limgala RP, Changsila E, Kamath R, Ioanou C, Goker-Alpan O. Ivanova M, et al. Blood Cells Mol Dis. 2018 Feb;68:100-105. doi: 10.1016/j.bcmd.2016.10.018. Epub 2016 Oct 27. Blood Cells Mol Dis. 2018. PMID: 27839983 Clinical Trial.

8

Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey.

Lau H, Belmatoug N, Deegan P, Goker-Alpan O, Schwartz IVD, Shankar SP, Panahloo Z, Zimran A. Lau H, et al. Blood Cells Mol Dis. 2018 Feb;68:226-231. doi: 10.1016/j.bcmd.2016.10.003. Epub 2016 Oct 20. Blood Cells Mol Dis. 2018. PMID: 27839985 Free article.

9

Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.

Limgala RP, Ioanou C, Plassmeyer M, Ryherd M, Kozhaya L, Austin L, Abidoglu C, Unutmaz D, Alpan O, Goker-Alpan O. Limgala RP, et al. PLoS One. 2016 Dec 12;11(12):e0168135. doi: 10.1371/journal.pone.0168135. eCollection 2016. PLoS One. 2016. PMID: 27942037 Free PMC article.

10

Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases.

Ivanova MM, Changsila E, Iaonou C, Goker-Alpan O. Ivanova MM, et al. PLoS One. 2019 Jan 11;14(1):e0210617. doi: 10.1371/journal.pone.0210617. eCollection 2019. PLoS One. 2019. PMID: 30633777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters